A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
Status:
Completed
Trial end date:
2019-01-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether curcumin, a drug and naturally-occurring
plant compound, is safe and effective in the treatment of primary sclerosing cholangitis
(PSC).